For over three decades, I have dedicated my career to advancing functional psychiatry, with low-dose lithium at the forefront of my work in helping patients with a myriad of mental health disorders, including irritability and impulsivity; along with addiction, Bipolar Disorder, Alzheimer’s, and major depressive disorder, to name just a few.

Benefits of Microdosing Lithium

While traditional psychiatry has often disregarded the therapeutic potential of this mineral in microdoses, my research and clinical experience have shown it to be an essential tool in achieving safe, effective, and an important component of personalized mental health care. The Psychiatry Redefined community has embraced this approach, seeing firsthand the transformative impact on our patients’ lives.

Today, I am encouraged by the growing recognition within mainstream psychiatry. A major U.S. research hospital and pharmaceutical company have launched a new study exploring the benefits of low-dose lithium for patients with major depressive disorder: Lithium Research Project.

This collaboration signals a turning point in our field, one that validates the work we’ve been doing for years and acknowledges the science-backed efficacy of this mineral for a range of mental health challenges. This large-scale research investment marks a long-overdue shift toward evidence-based functional treatments beyond symptom management.

Leading the Way in Holistic Care with Low-Dose Lithium Treatment

As our field moves toward a future that embraces functional and integrative approaches, I am proud of the dedicated Psychiatry Redefined clinicians at the forefront of this movement. Together, we have been leading the charge for more holistic, root-cause treatment options for mental health care. I am optimistic about what this shift means for our patients, our profession, and the path to a more personalized approach to mental well-being.

In health, 

James Greenblatt, MD
Founder & CMO, Psychiatry Redefined